Skip to main content
Article
Failure of Intensified Induction Therapy and Inability to Undergo Stem Cell Transplantation Predict Dismal Outcomes in Relapsed/Refractory MYC+ B-Cell Lymphoma
Blood (2014)
  • Ryan D. Cassaday, University of Washington
  • Philip A. Stevenson, University of Washington
  • Bronwyn H. Bryant, University of Washington
  • Cecilia Yeung, Fred Hutchinson Cancer Research Center
  • Brian G. Till, Fred Hutchinson Cancer Research Center
  • Stephen D. Smith, Fred Hutchinson Cancer Research Center
  • Edward N. Libby, Fred Hutchinson Cancer Research Center
  • Andrei R. Shustov, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Damian J. Green, Fred Hutchinson Cancer Research Center
  • Mary Philip, University of Washington
  • Johnnie J. Orozco, University of Washington
  • Min Fang, Fred Hutchinson Cancer Research Center
  • Leona Holmberg, Fred Hutchinson Cancer Research Center
  • William I. Bensinger, Fred Hutchinson Cancer Research Center
  • David G Maloney, Fred Hutchinson Cancer Research Center
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Publication Date
December 6, 2014
Citation Information
Ryan D. Cassaday, Philip A. Stevenson, Bronwyn H. Bryant, Cecilia Yeung, et al.. "Failure of Intensified Induction Therapy and Inability to Undergo Stem Cell Transplantation Predict Dismal Outcomes in Relapsed/Refractory MYC+ B-Cell Lymphoma" Blood Vol. 124 Iss. 21 (2014) p. 1731 - 1731
Available at: http://works.bepress.com/john-pagel/105/